Literature DB >> 21749298

Immune activation and target organ damage are consequences of hydrodynamic treatment but not delivery of naked siRNAs in mice.

Zsuzsanna Rácz1, Mária Godó, Csaba Révész, Péter Hamar.   

Abstract

Short-interfering RNAs (siRNAs), key mediators of RNA interference comprise a promising therapeutic tool, although side effects such as interferon (IFN) response are still not perfectly understood. Further, delivery to target organs is a major challenge, possibly associated with side effects including immune activation or organ damage. We investigated whether immune activation as a consequence of double-stranded RNA induced IFN response (Jak/STAT pathway activation or cytokine production) or target organ damage is induced by in vivo low-volume (LV) or high-volume (HV) hydrodynamic delivery or treatment with naked siRNA. NMRI mice were injected with naked siRNAs or saline by hydrodynamic injection (HDI) and positive control mice received polyinosinic-polycytidilic acid (poly I:C). LV (1 mL/mouse) and HV (10% of body weight) HDI were compared. After LV HDI, STAT1 and OAS1 gene expression inflammatory cytokine plasma levels and target organ injury were assessed. LV HDI induced slight alanine aminotransferase elevation and mild hepatocyte injury, whereas HV HDI resulted in high ALAT level and extensive hepatocyte necrosis. STAT1 or OAS1 was not induced by LV siRNA; however, HV saline led to a time-dependent slight increase in gene expression. Inflammatory cytokine plasma level and organ histology and functional parameters demonstrated no damage following LV HDI with or without siRNA. Our data demonstrate that naked siRNAs may be harnessed, without the induction of IFN response or immune activation, and that LV HDI is preferable, because HV HDI may cause organ damage.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21749298      PMCID: PMC3198622          DOI: 10.1089/nat.2010.0248

Source DB:  PubMed          Journal:  Nucleic Acid Ther        ISSN: 2159-3337            Impact factor:   5.486


  41 in total

1.  Hepatic uptake and gene expression mechanisms following intravenous administration of plasmid DNA by conventional and hydrodynamics-based procedures.

Authors:  N Kobayashi; T Kuramoto; K Yamaoka; M Hashida; Y Takakura
Journal:  J Pharmacol Exp Ther       Date:  2001-06       Impact factor: 4.030

2.  Lack of interferon response in animals to naked siRNAs.

Authors:  Jeremy D Heidel; Siwen Hu; Xian Fang Liu; Timothy J Triche; Mark E Davis
Journal:  Nat Biotechnol       Date:  2004-11-21       Impact factor: 54.908

3.  Interferon alpha activates NF-kappaB in JAK1-deficient cells through a TYK2-dependent pathway.

Authors:  Chuan He Yang; Aruna Murti; William J Valentine; Ziyun Du; Lawrence M Pfeffer
Journal:  J Biol Chem       Date:  2005-05-09       Impact factor: 5.157

4.  Mechanism of plasmid delivery by hydrodynamic tail vein injection. II. Morphological studies.

Authors:  Vladimir G Budker; Vladimir M Subbotin; Tatiana Budker; Magdolna G Sebestyén; Guofeng Zhang; Jon A Wolff
Journal:  J Gene Med       Date:  2006-07       Impact factor: 4.565

5.  Induction of an interferon response by RNAi vectors in mammalian cells.

Authors:  Alan J Bridge; Stephanie Pebernard; Annick Ducraux; Anne-Laure Nicoulaz; Richard Iggo
Journal:  Nat Genet       Date:  2003-07       Impact factor: 38.330

6.  Protection of renal ischemia injury using combination gene silencing of complement 3 and caspase 3 genes.

Authors:  Xiufen Zheng; Xusheng Zhang; Hongtao Sun; Biao Feng; Mu Li; Gang Chen; Costin Vladau; Dong Chen; Motohiko Suzuki; Lisa Min; Weihua Liu; Robert Zhong; Bertha Garcia; Anthony Jevnikar; Wei-Ping Min
Journal:  Transplantation       Date:  2006-12-27       Impact factor: 4.939

7.  In vivo delivery of caspase-8 or Fas siRNA improves the survival of septic mice.

Authors:  Doreen E Wesche-Soldato; Chun-Shiang Chung; Joanne Lomas-Neira; Lesley A Doughty; Stephen H Gregory; Alfred Ayala
Journal:  Blood       Date:  2005-06-07       Impact factor: 22.113

8.  Cationic liposome-mediated delivery of siRNAs in adult mice.

Authors:  Mouldy Sioud; Dag R Sørensen
Journal:  Biochem Biophys Res Commun       Date:  2003-12-26       Impact factor: 3.575

9.  Activation of the interferon system by short-interfering RNAs.

Authors:  Carol A Sledz; Michelle Holko; Michael J de Veer; Robert H Silverman; Bryan R G Williams
Journal:  Nat Cell Biol       Date:  2003-08-24       Impact factor: 28.824

10.  Determinants of cytokine induction by small interfering RNA in human peripheral blood mononuclear cells.

Authors:  Maryam Zamanian-Daryoush; Joao T Marques; Michael P Gantier; Mark A Behlke; Matthias John; Patricia Rayman; James Finke; Bryan R G Williams
Journal:  J Interferon Cytokine Res       Date:  2008-04       Impact factor: 2.607

View more
  9 in total

1.  The dynamic impact of hydrodynamic gene transfer on the immune system.

Authors:  Yan Wu; Shoubao Ma; Yonghao Liu; Lei Lei; Bo Hu; Haiyan Liu
Journal:  Int J Clin Exp Med       Date:  2015-06-15

2.  An adaptable system for improving transposon-based gene expression in vivo via transient transgene repression.

Authors:  Joseph E Doherty; Lauren E Woodard; Adham S Bear; Aaron E Foster; Matthew H Wilson
Journal:  FASEB J       Date:  2013-06-10       Impact factor: 5.191

3.  Successful liver-directed gene delivery by ERCP-guided hydrodynamic injection (with videos).

Authors:  Vivek Kumbhari; Ling Li; Klaus Piontek; Masaharu Ishida; Rongdang Fu; Bassem Khalil; Caroline M Garrett; Eleni Liapi; Anthony N Kalloo; Florin M Selaru
Journal:  Gastrointest Endosc       Date:  2018-07-03       Impact factor: 9.427

Review 4.  Liver-targeted gene therapy: Approaches and challenges.

Authors:  Rajagopal N Aravalli; John D Belcher; Clifford J Steer
Journal:  Liver Transpl       Date:  2015-06       Impact factor: 6.112

Review 5.  Fighting against kidney diseases with small interfering RNA: opportunities and challenges.

Authors:  Cheng Yang; Chao Zhang; Zitong Zhao; Tongyu Zhu; Bin Yang
Journal:  J Transl Med       Date:  2015-02-01       Impact factor: 5.531

6.  Safety assessment of liver-targeted hydrodynamic gene delivery in dogs.

Authors:  Kenya Kamimura; Tsutomu Kanefuji; Takeshi Yokoo; Hiroyuki Abe; Takeshi Suda; Yuji Kobayashi; Guisheng Zhang; Yutaka Aoyagi; Dexi Liu
Journal:  PLoS One       Date:  2014-09-24       Impact factor: 3.240

7.  Characterization of Putative Erythroid Regulators of Hepcidin in Mouse Models of Anemia.

Authors:  Cornel S G Mirciov; Sarah J Wilkins; Linda A Dunn; Gregory J Anderson; David M Frazer
Journal:  PLoS One       Date:  2017-01-30       Impact factor: 3.240

8.  Hyperactive piggyBac transposons for sustained and robust liver-targeted gene therapy.

Authors:  Mario Di Matteo; Emira Samara-Kuko; Natalie J Ward; Simon N Waddington; Simon N Waddingon; John H McVey; Marinee K L Chuah; Thierry VandenDriessche
Journal:  Mol Ther       Date:  2014-07-18       Impact factor: 11.454

9.  An inducible transgenic mouse model for immune mediated hepatitis showing clearance of antigen expressing hepatocytes by CD8+ T cells.

Authors:  Marcin Cebula; Aaron Ochel; Upneet Hillebrand; Marina C Pils; Reinhold Schirmbeck; Hansjörg Hauser; Dagmar Wirth
Journal:  PLoS One       Date:  2013-07-15       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.